|
CONFERENCE
SCHEDULE
The following sessions were added after the publication of the brochure (click on the link for a description):
CLINICIAN SESSIONS: PRACTICAL LEARNING FROM A PATIENT/FAMILY PERSPECTIVE
DAY 1: THURSDAY, JUNE 7, 2007
7:45 a.m. Registration & Continental Breakfast
8:30 a.m. Introduction
David J. Kupfer, MD
Setting the Stage
Sue Bergeson
8:45 a.m. SYMPOSIUM I – Clinical Trials – Pragmatic Data
Terence Ketter, MD - Chair
What Have We Learned about Bipolar Disorder form STEP-BD and Other Practical Trials
--Andrew A. Nierenberg, MD
Practical Lessons from Two Effectiveness Trials of Care Management and Psychoeducation for Bipolar Disorder
--Gregory Simon, MD, MPH
Observational Studies in Bipolar Disorder: What Have We Learned and What Cannot Be Learned
--Eduard Vieta, MD, PhD
10:15 a.m. Break
10:30 a.m. SYMPOSIUM II: Genetics, Neuroimaging and Boundaries of Bipolar Disorder
J. Raymond DePaulo, Jr., MD – Chair
Prospects for Identification for Bipolar Disorder Risk Genes through Whole Genome Analyses
--Wade H. Berrettini, MD, PhD
Neuronal Plasticity Cascades: Genes to Behavior Pathways in the Pathophysiology and Treatment of Bipolar Disorder
--Husseini K. Manji, MD
Identifying Biomarkers of Bipolar Disorder: The Role of Neuroimaging and Neurocognition
--Mary L. Phillips, MD
12:00 p.m. Lunch (on your own)
1:00 p.m. Report from the National Institute of Mental Health
“NIMH Update”
Thomas R. Insel, MD
2:30 p.m. Break
2:45 p.m. Concurrent Sessions I
T1. Treatment of Bipolar Depression I
Joseph Calabrese, MD
Paul E. Keck, Jr., MD
Willem A. Nolen, MD, PhD
T2. Diagnostic Guidelines I
Mark A. Frye, MD
Terence Ketter, MD
T3. Treatment Guidelines for Bipolar Disorder I
Philip Mitchell, MBBS, FRANZCP, FRCPsych
Gary S. Sachs, MD
T4. Childhood Bipolar Disorder (Role of ADHD)
David A. Axelson, MD
Boris Birmaher, MD
Kiki D. Chang, MD
T5. What Are the Limits of Psychosocial Treatment for Bipolar Disorder?
Sagar V. Parikh, MD, FRCPC
Gregory Simon, MD, MPH
T6. Managing Alcohol and Substance Abuse in Patients with Bipolar Disorder
Ihsan Salloum, MD
Roger D. Weiss, MD
T7. Advances in Schizophrenia: Lessons for Bipolar Disorder
S. Charles Schulz, MD
Carol A. Tamminga, MD
T8. Using Peer Run Support Groups as a Therapeutic Augmentation to Care
Rodney Elgie
Stephen Propst, MBA
4:15 p.m. Adjournment
4:30 p.m. -
6:00 p.m. Poster Session
7:00 p.m. - Reception
10:00 p.m. Grand Concourse Restaurant Back to Top
DAY 2: FRIDAY, JUNE 8, 2007
7:45 a.m. Registration & Continental Breakfast
8:30 a.m. Introduction
Ellen Frank, PhD
8:45 a.m. SYMPOSIUM III - The Bipolar Spectrum and Bipolar II Disorder
Joseph Calabrese, MD - Chair
Developmental Issues in the Pediatric Bipolar Spectrum
--Kiki D. Chang, MD
Treatment of Bipolar II Disorder and Consideration of the Bipolar Spectrum
--Trisha Suppes, MD, PhD
Role of Psychosocial Interventions in Bipolar II Disorder: What Do We Know
--Holly Swartz, MD
10:15 a.m. Break
10:30 a.m. SYMPOSIUM IV – Bipolar Disorder and Concurrent Psychiatric/Medical Disorders
Valentim Gentil, MD, PhD - Chair
Co-occurrence of Bipolar Disorder, Obsessive Compulsive Disorder, and Impulse Control Disorders
--Paul E. Keck, Jr., MD
High Rates of Medical Comorbidities in Bipolar Disorder Partially Explained by Sheared Genetics Factors
--Willem A. Nolen, MD, PhD
Medical and Psychiatric Comorbidities of Bipolar Disorder
--Allan H. Young, MD, PhD
12:00 p.m. Lunch (on your own)
1:00 p.m. Concurrent Sessions II
F1. Combined Treatment (Pharmacological & Psychotherapeutic)
Holly Swartz, MD
Michael E. Thase, MD
F2. Diagnostic Issues and Treatment – Geriatrics
Ariel Gildengers, MD
Benoit H. Mulsant, MD, MS
F3. Diagnostic Issues and Nosology
(Transition through Adolescence from Childhood Bipolar Disorder)
David A. Axelson, MD
Boris Birmaher, MD
F4. Cognitive Behavioral Therapy
Noreen Reilly-Harrington, PhD
Jan Scott, MD, FRCPsych
F5. Interpersonal and Social Rhythm Therapy
Ellen Frank, PhD
Jodi M. Gonzalez, PhD
F6. Family Focused Therapy
Elizabeth L. George, PhD
David J. Miklowitz, PhD
F7. Psychoeducation
Francesc Colom, PsyD, MSc, PhD
Eduard Vieta, MD, PhD
F8. Medical Monitoring: Who Should be Responsible for Which Conditions:
What Should be Monitored and When?
Andrea Fagiolini, MD
Edward S. Friedman, MD
F9. Woman’s Reproductive Health and Bipolar Disorder
Lauren B. Marangell, MD
Katherine L. Wisner, MD
F10. The Seven Dirty Words – Practical Tips for Improving Adherence and Outcome
Brenda Bergeson, MD
Sue Bergeson
Rodney Elgie
Matthew G. Mattson, MS
2:30 p.m. Break
2:45 p.m. Concurrent Rapid Communication Session (I & II)
Session I:
pCREB as a Biochemical Phenotype in Genetic Studies of Bipolar Disorder
Martin Alda, MD, FRCPC
Neuropsychological and Electrophysiological Indices of Neurocognitive
Dysfunction in Bipolar II Disorder
Stein Andersson, PhD
Antioxidant Treatment of the Glutathione Deficiency in Bipolar Disorder
with N-Acetyl Cysteine: A Double Blind Randomized Placebo Controlled Trial
Michael Berk, MD, PhD
Differences in Brain Activation during a Working Memory Task in Patients
with Bipolar Disorder Compared to their Healthy First Degree Relatives and Control Subjects
Sophia Frangou, MD, PhD
General and Specific Cognitive Deficits in Bipolar Depression: The Brief
Assessment of Cognition in Affective Disorders (BAC-A)
Richard Keefe, PhD
Lamotrigine versus lithium in prophylaxis of bipolar disorder: a randomized study
Rasmus W. Licht, MD, PhD
Efficacy of a Protein Kinase C Inhibitor in the Treatment of Acute Mania:
A Double-Blind, Placebo-Controlled Study
Carlos A. Zarate, Jr., MD
Session II:
The Wellcome Trust Case Control Consortium (WTCCC) genome-wide association
study of 2000 cases of bipolar disorder and 3000 controls
Nick Craddock, MD, PhD, FRCPsych
Childhood Affective Trauma in Bipolar Affective Disorder
Marion Leboyer, MD, PhD
Recovery from Depression in Patients with Bipolar Disorder and Comorbid
Substance and Alcohol Use Disorders: Prospective Findings from the
Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)
Michael J. Ostacher, MD, PhD
Elevated Serum Levels of C-reactive Protein are Associated with
Mania Symptoms in Outpatients with Bipolar Disorder
Faith Dickerson, PhD
Nomenclature in Course and Outcome in Bipolar Disorders
Mauricio Tohen, MD, DrPh, MBA
Does Cannabis Use Impact on Treatment Outcome in Bipolar Illness?
A Longitudinal Analysis
Inge van Rossum, MSc
Self-reported Access to Medical and Psychiatric Care in Patients
with Bipolar Disorder
John E. Zeber, PhD
2:45 p.m Peer Support/Advocacy Forum: Consumer Involvement in Providing Direct Care
William Ashdown
Peter C. Ashenden
Rodney Elgie
Lisa C. Goodale, MSW
4:15 p.m. Adjournment
4:30 p.m. -
6:00 p.m. Poster Session
7:30 p.m. Mogens Schou Awards
Carnegie Museums of Pittsburgh
8:30 p.m. Dinner
Carnegie Museums of Pittsburgh
Back to Top
DAY 3: SATURDAY, JUNE 9, 2007
7:45 a.m. Registration
Continental Breakfast
8:30 a.m. Introduction
Michael E. Thase, MD
8:45 a.m. Concurrent Sessions III
S1. Essential Ingredients of Psychotherapy
David J. Miklowitz, PhD
S2. The Functional and Economic Burden of Bipolar Disorder
Sagar V. Parikh, MD, FRCPC
S3. Advocacy Workshop
Sue Bergeson
Ellen Frank, PhD
S4. Career Training for Bipolar Disorder
Mark Chavez, PhD
S5. Functioning: Outcomes
Mark S. Bauer, MD
S6. Cognition, Cognitive Neuroscience and Bipolar Disorder
Wayne Drevets, MD
Sophia Frangou, MD, MSc, PhD, MRCPsych
Guy Goodwin, MD
Advanced Workshops on Psychosocial Therapy
S7A: Cognitive Behavioral Therapy
Noreen Reilly-Harrington, PhD
Jan Scott, MD, FRCPsych
S7B: Interpersonal and Social Rhythm Therapy
Debra Frankel, DCSW
Jodi M. Gonzalez, PhD
S7C: Family Focused Therapy
Elizabeth L. George, PhD
S7D: Psychoeducation
Francesc Colom, PsyD, MSc, PhD
Eduard Vieta, MD, PhD
10:15 a.m. Break
10:30 a.m. SYMPOSIUM V – International Perspectives
Lakshmi N. Yatham, MB, FRCPC - Chair
The Paradox of a Public Mental Health System Submitted to Dehospitalizaton: High Admission Pressures to
Vanishing Hospital Services
--Valentim Gentil, MD, PhD
International Perspectives: England
--Guy Goodwin, MD
International Perspectives on Bipolar Disorder: Australia and New Zealand
--Philip Mitchell, MBBS, FRANZCP, FRCPsych
12:00 p.m. Lunch (on your own)
1:00 p.m. SYMPOSIUM VI – DSM, ICD, WHO and Beyond
David J. Kupfer, MD – Chair
Consumer Perspective: DSM, ICD, WHO and Beyond
--Sue Bergeson
The DMS-V Development Process: An Overview of Progress Made and Future Challenges
--Darrel A. Regier, MD, MPH
Nosology of Bipolar Disorder: What Needs to Change in DSM-V and Beyond
--Lakshmi N. Yatham, MB, FRCPC
3:00 p.m. Concurrent Sessions IV
Meet the Doctors
David Axelson, MD
Andrea Fagiolini, MD
Vishwajit Nimgaonkar, MD
Michael E. Thase, MD
4:15 p.m. Adjournment
Back
to Top |
